» Articles » PMID: 33505713

Ulinastatin Alleviates Traumatic Brain Injury by Reducing Endothelin-1

Overview
Journal Transl Neurosci
Specialty Neurology
Date 2021 Jan 28
PMID 33505713
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Brain edema is one of the major causes of fatality and disability associated with injury and neurosurgical procedures. The goal of this study was to evaluate the effect of ulinastatin (UTI), a protease inhibitor, on astrocytes in a rat model of traumatic brain injury (TBI).

Methodology: A rat model of TBI was established. Animals were randomly divided into 2 groups - one group was treated with normal saline and the second group was treated with UTI (50,000 U/kg). The brain water content and permeability of the blood-brain barrier were assessed in the two groups along with a sham group (no TBI). Expression of the glial fibrillary acidic protein, endthelin-1 (ET-1), vascular endothelial growth factor (VEGF), and matrix metalloproteinase 9 (MMP-9) were measured by immunohistochemistry and western blot. Effect of UTI on ERK and PI3K/AKT signaling pathways was measured by western blot.

Results: UTI significantly decreased the brain water content and extravasation of the Evans blue dye. This attenuation was associated with decreased activation of the astrocytes and ET-1. UTI treatment decreased ERK and Akt activation and inhibited the expression of pro-inflammatory VEGF and MMP-9.

Conclusion: UTI can alleviate brain edema resulting from TBI by inhibiting astrocyte activation and ET-1 production.

Citing Articles

Neuroprotective effects of ulinastatin on Escherichia coli meningitis rats through inhibiting PKCα phosphorylation and reducing zonula occludens-1 degradation.

Zheng X, Wang J, Su H, Wu L, Zhang Y, Tang Q Sci Rep. 2024; 14(1):21236.

PMID: 39261565 PMC: 11390977. DOI: 10.1038/s41598-024-72097-5.


Effects of ulinastatin therapy in deep vein thrombosis prevention after brain tumor surgery: A single-center randomized controlled trial.

Tao Y, Han Q, Jiao W, Yang L, Wang F, Xue S World J Clin Cases. 2023; 11(31):7583-7592.

PMID: 38078125 PMC: 10698442. DOI: 10.12998/wjcc.v11.i31.7583.


Ulinastatin in the treatment of severe acute pancreatitis: A single-center randomized controlled trial.

Wang S, Jiao W, Zhang J, Zhang J, Tao Y, Jiang Q World J Clin Cases. 2023; 11(19):4601-4611.

PMID: 37469723 PMC: 10353502. DOI: 10.12998/wjcc.v11.i19.4601.


Roles of Astrocytic Endothelin ET Receptor in Traumatic Brain Injury.

Michinaga S, Hishinuma S, Koyama Y Cells. 2023; 12(5).

PMID: 36899860 PMC: 10000579. DOI: 10.3390/cells12050719.


Ulinastatin alleviates early brain injury after intracerebral hemorrhage by inhibiting oxidative stress and neuroinflammation via ROS/MAPK/Nrf2 signaling pathway.

Wu X, Jiao W, Chen J, Tao Y, Zhang J, Wang Y Acta Cir Bras. 2022; 37(6):e370606.

PMID: 36074399 PMC: 9448248. DOI: 10.1590/acb370606.


References
1.
Gao W, Zhao Z, Yu G, Zhou Z, Zhou Y, Hu T . VEGI attenuates the inflammatory injury and disruption of blood-brain barrier partly by suppressing the TLR4/NF-κB signaling pathway in experimental traumatic brain injury. Brain Res. 2015; 1622:230-9. DOI: 10.1016/j.brainres.2015.04.035. View

2.
Yasui M . [Aquaporin4 (AQP4) in brain disorder]. Nihon Yakurigaku Zasshi. 2019; 153(5):231-234. DOI: 10.1254/fpj.153.231. View

3.
Ikeshima-Kataoka H . Neuroimmunological Implications of AQP4 in Astrocytes. Int J Mol Sci. 2016; 17(8). PMC: 5000703. DOI: 10.3390/ijms17081306. View

4.
Salehi A, Zhang J, Obenaus A . Response of the cerebral vasculature following traumatic brain injury. J Cereb Blood Flow Metab. 2017; 37(7):2320-2339. PMC: 5531360. DOI: 10.1177/0271678X17701460. View

5.
He J, Li H, Yang L, Cheng K . Involvement of Endothelin-1, HS and Nrf2 in Beneficial Effects of Remote Ischemic Preconditioning in Global Cerebral Ischemia-Induced Vascular Dementia in Mice. Cell Mol Neurobiol. 2019; 39(5):671-686. PMC: 11462842. DOI: 10.1007/s10571-019-00670-y. View